Moreover, the simulations confirmed that the Cagri P37 had weaker interactions with the ECDs leading to greater uncoupling of the peptide C-terminus from the ECDs (Supplementary Movie 1, Supplementary Tables 4, 5), and parallel increases in the dynamics of the peptide as it engaged with the CTR TM bundle, including F23
8 weeks (0.251.0 mg/wk): ~1 vial 12 weeks (gradual to 1.7 mg/wk): ~2 vials 16 weeks (gradual to 2.44.5 mg/wk): ~3 vials Insulin Syringes (U-100, 1 mL) Per week: 1 syringe (once-weekly dosing) 12 weeks: 12 syringes 24 weeks: 24 syringes 48 weeks: 48 syringes Bacteriostatic Water (10 mL bottles) Use 2.0 mL (gradual) or 1.0 mL (advanced) per vial for reconstitution
AOD 9604 vs other fat loss peptides You're probably considering other options
Key highlights Lyophilized 5 mg vial Supplied as a sterile lyophilized powder in a sealed glass vial for stable, long-term storage
The Faghihi 2021 study found that 0.6 mm performed equally well as 1.2 mm, suggesting shallower depths may be sufficient for some patients
The volume needed is the same regardless of source, but quality affects whether the peptide stays in solution
